Switching outpatients between atypical antipsychotics

Ann M. Bogan, Eric Shellhorn, E. Sherwood Brown, Conway Mcdanald, Trisha Suppes

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

1. Some reports have suggested an increase in symptoms when switching patients with psychosis from clozapine to other atypical antipsychotics. 2. No data are available on switching between atypical antipsychotics other than clozapine, though this is common in clinical practice. 3. Six patients with schizophrenia or schizoaffective disorder, bipolar type were switched to quetiapine after finishing a clinical trial of sertindole. 4. During the observation period of two to ten weeks no subjects worsened and one improved. Side effects were mild. 5. These preliminary data suggest that switching between some atypical agents may be well tolerated. Larger controlled trials are needed to confirm this observation.

Original languageEnglish (US)
Pages (from-to)351-355
Number of pages5
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume24
Issue number2
DOIs
StatePublished - Feb 2000

Fingerprint

Clozapine
Psychotic Disorders
Antipsychotic Agents
Outpatients
Schizophrenia
Observation
Clinical Trials
sertindole
Quetiapine Fumarate

Keywords

  • Atypical antipsychotic
  • Quetiapine
  • Schizoaffective disorder
  • Schizophrenia
  • Sertindole
  • Switching

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Switching outpatients between atypical antipsychotics. / Bogan, Ann M.; Shellhorn, Eric; Brown, E. Sherwood; Mcdanald, Conway; Suppes, Trisha.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 24, No. 2, 02.2000, p. 351-355.

Research output: Contribution to journalArticle

Bogan, Ann M. ; Shellhorn, Eric ; Brown, E. Sherwood ; Mcdanald, Conway ; Suppes, Trisha. / Switching outpatients between atypical antipsychotics. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2000 ; Vol. 24, No. 2. pp. 351-355.
@article{aab930aad0ac48f88d3342ee2f9de766,
title = "Switching outpatients between atypical antipsychotics",
abstract = "1. Some reports have suggested an increase in symptoms when switching patients with psychosis from clozapine to other atypical antipsychotics. 2. No data are available on switching between atypical antipsychotics other than clozapine, though this is common in clinical practice. 3. Six patients with schizophrenia or schizoaffective disorder, bipolar type were switched to quetiapine after finishing a clinical trial of sertindole. 4. During the observation period of two to ten weeks no subjects worsened and one improved. Side effects were mild. 5. These preliminary data suggest that switching between some atypical agents may be well tolerated. Larger controlled trials are needed to confirm this observation.",
keywords = "Atypical antipsychotic, Quetiapine, Schizoaffective disorder, Schizophrenia, Sertindole, Switching",
author = "Bogan, {Ann M.} and Eric Shellhorn and Brown, {E. Sherwood} and Conway Mcdanald and Trisha Suppes",
year = "2000",
month = "2",
doi = "10.1016/S0278-5846(99)00095-0",
language = "English (US)",
volume = "24",
pages = "351--355",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Switching outpatients between atypical antipsychotics

AU - Bogan, Ann M.

AU - Shellhorn, Eric

AU - Brown, E. Sherwood

AU - Mcdanald, Conway

AU - Suppes, Trisha

PY - 2000/2

Y1 - 2000/2

N2 - 1. Some reports have suggested an increase in symptoms when switching patients with psychosis from clozapine to other atypical antipsychotics. 2. No data are available on switching between atypical antipsychotics other than clozapine, though this is common in clinical practice. 3. Six patients with schizophrenia or schizoaffective disorder, bipolar type were switched to quetiapine after finishing a clinical trial of sertindole. 4. During the observation period of two to ten weeks no subjects worsened and one improved. Side effects were mild. 5. These preliminary data suggest that switching between some atypical agents may be well tolerated. Larger controlled trials are needed to confirm this observation.

AB - 1. Some reports have suggested an increase in symptoms when switching patients with psychosis from clozapine to other atypical antipsychotics. 2. No data are available on switching between atypical antipsychotics other than clozapine, though this is common in clinical practice. 3. Six patients with schizophrenia or schizoaffective disorder, bipolar type were switched to quetiapine after finishing a clinical trial of sertindole. 4. During the observation period of two to ten weeks no subjects worsened and one improved. Side effects were mild. 5. These preliminary data suggest that switching between some atypical agents may be well tolerated. Larger controlled trials are needed to confirm this observation.

KW - Atypical antipsychotic

KW - Quetiapine

KW - Schizoaffective disorder

KW - Schizophrenia

KW - Sertindole

KW - Switching

UR - http://www.scopus.com/inward/record.url?scp=0034143693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034143693&partnerID=8YFLogxK

U2 - 10.1016/S0278-5846(99)00095-0

DO - 10.1016/S0278-5846(99)00095-0

M3 - Article

C2 - 10800756

AN - SCOPUS:0034143693

VL - 24

SP - 351

EP - 355

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 2

ER -